Neoplex
MarketedMolecular-diagnostics brand that led the company's export growth in 2026.
FROM PUBLIC EVENTS · 2026-11-15
Global approvals · expansion Exports of its molecular diagnostic kits grew and it returned to profit in the second quarter.
Roles often seen at this stageRegulatory affairs · Sales & marketing · Research & development
A maker of molecular diagnostic kits for infectious diseases that returned to profit in the second quarter of 2026 as exports grew.
Molecular-diagnostics brand that led the company's export growth in 2026.
Reported a second-quarter operating profit as exports expanded.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.